In our study, overexpression or knockdown of LRRC8A expression could alter the oxaliplatin resistance in native HCT116 cells, which suggest that LRRC8A contribute to the obtainment of oxaliplatin resistance in colon cancer cells. The gene discussed is LRRC8A; the disease is malignant colon neoplasm.